IP Library Granted Patent US 8,912,323
Granted Patent B2
US 8,912,323 · App. 13/504,046 · Granted Dec 16, 2014

Multifunctional small molecules

Inventors: James R. Baker, Jr. (Ann Arbor, MI); Hong Zong (Ann Arbor, MI); Thommey P. Thomas (Dexter, MI)
Assignee: The Regents of the University of Michigan
C08G83/003A61K47/48107A61K47/48207
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,912,323
App. No.
13/504,046
Granted
Dec 16, 2014
Kind
B2
Abstract

The present invention relates to dendrimer synthesis. Specifically, the present invention relates to triazine scaffolds capable of click chemistry for one-step synthesis of functionalized dendrimers, and methods of making and using the same.

Claims (14)

1. A composition comprising a PAMAM dendrimer conjugated with a triazine compound, wherein said triazine compound is selected from the group consisting of

2. The composition of claim 1 , wherein said PAMAM dendrimer is conjugated with said triazine compound via a 3-azido-coumarine linkage agent.

3. The composition of claim 1 , wherein said triazine compound is conjugated with one or more ligands.

4. The composition of claim 3 , wherein said one or more ligands are independently selected from the group consisting of a therapeutic agent, a targeting agent, an imaging agent, and a trigger agent.

5. The composition of claim 3 , wherein said one or more ligands are methotrexate, folic acid, and 3-azido-coumarine.

6. A method of synthesizing a functionalized dendrimer, said method comprising:

a) providing an alkyne-modified PAMAM dendrimer and a triazine compound, wherein said triazine compound is selected from the group consisting of

and

b) conjugating said alkyne-modified PAMAM dendrimer with said triazine compound.

7. The method of claim 6 , wherein conjugating of said alkyne-modified PAMAM dendrimer with said triazine compound occurs via a click chemistry reaction.

8. The method of claim 6 , wherein said PAMAM dendrimer is conjugated with said triazine compound via a 3-azido-coumarine linkage agent.

9. The method of claim 6 , further comprising step c) conjugating one or more ligands with said triazine compound.

10. The method of claim 9 , wherein said one or more ligands are selected from the group consisting of a therapeutic agent, a targeting agent, an imaging agent, and a trigger agent.

11. The method of claim 9 , wherein said one or more ligands are methotrexate and folic acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2012
From: BAKER, JAMES R., JR.; ZONG, HONG; THOMAS, THOMMEY P.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 028334/0723 →
CONFIRMATORY LICENSE Recorded May 1, 2012
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028133/0642 →
Continuity (2)
Provisional Application 61256699 · Oct 30, 2009
Related Publication 20120259114A1 · Oct 11, 2012